Stock DNA
Pharmaceuticals & Biotechnology
CAD 18 Million (Micro Cap)
NA (Loss Making)
NA
0.00%
1.03
-40.41%
0.03
Revenue and Profits:
Net Sales:
159 Million
(Quarterly Results - Dec 2024)
Net Profit:
-230 Million
Total Returns (Price + Dividend) 
TimePeriod
Price Return
Dividend Return
Total Return
3 Months
-61.25%
0%
-61.25%
6 Months
-80.62%
0%
-80.62%
1 Year
-94.54%
0%
-94.54%
2 Years
-86.04%
0%
-86.04%
3 Years
-97.95%
0%
-97.95%
4 Years
-99.56%
0%
-99.56%
5 Years
-98.58%
0%
-98.58%
Ayr Wellness, Inc. for the last several years.
Risk Adjusted Returns v/s 
News
No Recent News for the Company
Announcements 
No announcement available
Corporate Actions 
No corporate action available
Quality key factors 
Factor
Value
Sales Growth (5y)
44.88%
EBIT Growth (5y)
1.57%
EBIT to Interest (avg)
-1.12
Debt to EBITDA (avg)
25.28
Net Debt to Equity (avg)
1.03
Sales to Capital Employed (avg)
0.43
Tax Ratio
13.44%
Dividend Payout Ratio
0
Pledged Shares
0
Institutional Holding
0.52%
ROCE (avg)
0.26%
ROE (avg)
0
Valuation key factors
Factor
Value
P/E Ratio
NA (Loss Making)
Industry P/E
Price to Book Value
0.05
EV to EBIT
-11.13
EV to EBITDA
8.44
EV to Capital Employed
0.53
EV to Sales
0.93
PEG Ratio
NA
Dividend Yield
NA
ROCE (Latest)
-4.79%
ROE (Latest)
-40.41%
Technicals key factors
Indicator
Weekly
Monthly
MACD
Mildly Bullish
Mildly Bullish
RSI
No Signal
Bullish
Bollinger Bands
Mildly Bearish
Mildly Bearish
Moving Averages
Bearish (Daily)
KST
Mildly Bullish
Bearish
Dow Theory
Bearish
Bearish
OBV
No Trend
No Trend
Shareholding Snapshot : Dec 2024
Shareholding Compare (%holding) 
Majority shareholders
Foreign Institutions
Domestic Funds
Held in 0 Schemes (0%)
Foreign Institutions
Held by 10 Foreign Institutions (0.52%)
Strategic Entities with highest holding
Highest Public shareholder
Quarterly Results Snapshot (Consolidated) - Dec'24 - QoQ
Dec'24
Sep'24
Change(%)
Net Sales
159.40
155.90
2.25%
Operating Profit (PBDIT) excl Other Income
5.70
9.70
-41.24%
Interest
28.10
27.60
1.81%
Exceptional Items
-163.20
-4.70
-3,372.34%
Consolidate Net Profit
-229.60
-68.90
-233.24%
Operating Profit Margin (Excl OI)
-151.10%
-122.70%
-2.84%
USD in Million.
Net Sales
QoQ Growth in quarter ended Dec 2024 is 2.25% vs -2.87% in Sep 2024
Consolidated Net Profit
QoQ Growth in quarter ended Dec 2024 is -233.24% vs -28.07% in Sep 2024
Annual Results Snapshot (Consolidated) - Dec'24
Dec'24
Dec'23
Change(%)
Net Sales
635.20
625.80
1.50%
Operating Profit (PBDIT) excl Other Income
65.50
86.70
-24.45%
Interest
107.20
53.20
101.50%
Exceptional Items
-276.20
17.00
-1,724.71%
Consolidate Net Profit
-496.40
-125.70
-294.91%
Operating Profit Margin (Excl OI)
-83.10%
-57.60%
-2.55%
USD in Million.
Net Sales
YoY Growth in year ended Dec 2024 is 1.50% vs 3.23% in Dec 2023
Consolidated Net Profit
YoY Growth in year ended Dec 2024 is -294.91% vs 62.21% in Dec 2023
About Ayr Wellness, Inc. 
Ayr Wellness, Inc.
Pharmaceuticals & Biotechnology
Ayr Strategies Inc. is a vertically integrated, United States multi-state cannabis operator. With the operations in Massachusetts and Nevada, the Company cultivates and manufactures branded cannabis products for distribution through its network of retail outlets and through third party stores.






